Dexin SA
4.9 FTEThe score of Dexin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -50 % Equity -40 % Total assets -48 % Headcount (avg FTE) -12 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dexin's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €26.5m | ||||
| Net result | −316,700 € | ||||
| Equity | €7.13m | ||||
| Cash | 272 € | ||||
| EBITDA | −281,626 € | ||||
| Total assets | €38.9m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Oct 2026
- Year ended 31 Dec 2024filed on 10 Dec 2025
- Year ended 31 Dec 2023filed on 08 Aug 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 27 Jul 2022
Dexin's financial analysis
- Solvency18.3%sector median: 18.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dexin
Dexin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0471.394.462
- VAT number
- BE0471394462
- Peppol
- Registered · 0208:0471394462 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 09 Mar 2000
- Registered office
- 1180 Uccle
- Size
- Micro · 4.9 FTE
- Latest accounts
- 2025 · filed on 30 Oct 2026
- Activity
- Buying and selling of own real estate (NACE 68110)
Dexin (SA) has been based in Uccle since 2000, active in: buying and selling of own real estate. For 2025, it reports revenue of €26.5m, a net loss of 316,700 € and equity of €7.13m. With 4.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 18.3%, below the median of its sector (18.6%).
Companies similar to Dexin
Companies in the same business, of comparable size and area, outside its group.
- Herpain Investissement Buying and selling of own real estate Uccle · balance sheet €23.5m
- Alfa Consulting Buying and selling of own real estate Sint-Genesius-Rode · balance sheet €20.2m
- Strategies AND Telecommunications Development of building projects Brussels · balance sheet €41.1m
- Bailli Properties Construction of residential and non-residential buildings Ixelles · balance sheet €37.3m
- Belgian Land Properties Buying and selling of own real estate Brussels · balance sheet €15.4m
- Deknudt Invest EN Consult Business and other management consultancy activities Deerlijk · balance sheet €16.5m
- AXIO Business and other management consultancy activities Wielsbeke · balance sheet €9.46m
- VDD Invest Market research and public opinion polling Veurne · balance sheet €9.72m
Frequently asked questions about Dexin
What is the revenue of Dexin?
According to the 2025 annual accounts filed with the NBB, the revenue of Dexin amounts to 26,463,296 €.
What is the VAT number of Dexin?
In Belgium, the VAT number is the company number prefixed with BE: BE0471394462 for Dexin, if the company is VAT-registered. Its company number (CBE) is 0471.394.462.
Where is the registered office of Dexin?
According to the CBE register, the registered office of Dexin is in 1180 Uccle.
What is the equity of Dexin?
At the close of the 2025 financial year, the equity of Dexin amounts to 7,133,529 €, a solvency of 18.3% of total assets.
How many people work at Dexin?
4.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Dexin?
The register lists 7 active mandates at Dexin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dexin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →